Back to Rheumatology
Rheumatologyv2010Evidence-Based

Indian Takayasu Clinical Activity Score (ITAS2010)

Differentiates between active and inactive disease in Takayasu arteritis (TA). The ITAS2010 is a validated clinical activity measure specifically developed for Takayasu arteritis, incorporating 44 clinical items with emphasis on cardiovascular manifestations (33 out of 44 items). The score was developed from the Disease Extent Index (DEI.Tak) and validated in over 300 TA patients with excellent inter-observer reliability (IRR 0.97). It assesses new or worsening symptoms within the past 3 months across multiple organ systems including systemic, abdominal, genitourinary, renal, neurological, and cardiovascular domains. Seven key cardiovascular items carry higher weight (2 points each) reflecting their clinical significance in disease activity assessment.

Clinical Input Parameters

Clinical Assessment
Awaiting Parameters
score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Indian Takayasu Clinical Activity Score (ITAS2010) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within rheumatology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Score = Sum of all positive items: Systemic (3 items, 1 point each) + Abdominal (1 item, 1 point) + Genitourinary (1 item, 1 point) + Renal (systolic BP >140: 1 point, diastolic BP >90: 2 points) + Neurological (4 items: stroke 2 points, others 1 point each) + Cardiovascular (8 items: bruits, pulse inequality, new loss of pulses, claudication, carotidynia 2 points each; aortic incompetence, MI/angina, cardiomyopathy 1 point each)

Clinical Pearls & Practice Notes

  • Assesses new or worsening symptoms within the past 3 months only
  • Validated in over 300 Takayasu arteritis patients with excellent inter-observer reliability (IRR 0.97)
  • Score <2 indicates inactive disease; score ≥2 indicates active disease requiring treatment
  • Seven key cardiovascular items are weighted at 2 points each due to clinical significance
  • Focuses predominantly on vascular manifestations (cardiovascular system features)
  • Useful for monitoring disease activity and treatment response in clinical practice
  • Can be combined with acute phase reactants (ESR/CRP) as ITAS-A for enhanced assessment
  • Higher scores indicate greater disease activity and need for therapeutic intervention
  • Should be used in conjunction with clinical judgment and imaging studies
  • Regular monitoring recommended to assess treatment response and disease progression

Evidence & Literature Citations

  1. Misra R, Danda D, Rajappa SM, et al. Development and initial validation of the Indian Takayasu Clinical Activity Score (ITAS2010). Rheumatology (Oxford). 2013 Oct;52(10):1795-801. doi: 10.1093/rheumatology/ket128.
  2. Abularrage CJ, Sidawy AN, White PW, et al. Evaluation of the clinical effectiveness of percutaneous transluminal angioplasty for Takayasu arteritis. J Vasc Surg. 2007;45(2):314-318.
  3. Kerr GS, Hallahan CW, Giordano J, et al. Takayasu arteritis. Ann Intern Med. 1994;120(11):919-929.

Score Interpretation Ranges

Inactive0 – 1 pts

Score <2 points

Active2 – 29 pts

Score ≥2 points

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.